ARCHIVES

Patient Accrual Up More Than 20% This Year Despite Lack Of Significant New Money For Group

This article is from The Cancer Letter archive.

Vol. 14 No. 45 | November 18, 1988

Download PDF Visit The Full Archive

Related Articles

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

DCE Board Approves Concept For New $850,000 Year Grant Program To Study Viruses In Cervical Cancer

November 9, 1984

DCPC Advisors OK Expansion Of Science Enrichment Program, Other Concepts

November 1, 1991

Blochs to Sponsor “Fighting Cancer”

May 9, 1986

Miami Radiotherapy Program Defended

June 30, 1978

DCPC Board Agrees to Commit $62 Million To Trials Of Prostate, Lung, Colorectal Cancer Screening

October 20, 1989